Pluri Inc.

The momentum for this stock is not very good. Pluri Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Pluri Inc..

News

Analyzing Pluri (NASDAQ:PLUR) and Tevogen Bio (NASDAQ:TVGN)

Ticker Report Pluri (NASDAQ:PLUR - Get Free Report) and Tevogen Bio (NASDAQ:TVGN - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies...\n more…

Pluri trading resumes

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Pluri trading halted, volatility trading pause

Pluri signs tech transfer, manufacturing agreement with Kadimastem

Pluri's CDMO Selected to Manufacture Kadimastem's Novel Cell Therapy Product Candidates

Globe Newswire PluriCDMO , the Company's contract development and manufacturing organization, recognized as a leading manufacturing partner offering scalability and mass scale production to a growing number of...\n more…

Critical Comparison: Pluri (NASDAQ:PLUR) & Relay Therapeutics (NASDAQ:RLAY)

Ticker Report Pluri (NASDAQ:PLUR - Get Free Report) and Relay Therapeutics (NASDAQ:RLAY - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two...\n more…